PI4K III beta inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePI4K III beta inhibitors (GlaxoSmithKline)
Drug Alias NameGSK-480
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase beta inhibitors
TargetsPhosphatidylinositol 4-kinase beta
Therapy Area/IndicationsEnterovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Llc
Active IndicationsN/A
Inactive IndicationsEnterovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A